Home » Previous Page » News Item:

AvKARE, LLC. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension, USP 750 mg/5 mL Due to Potential Bacillus Cereus Contamination

AvKARE, LLC. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension, USP 750 mg/5 mL Due to Potential Bacillus Cereus Contamination


AvKARE, LLC. is voluntarily recalling lot # AW0221A of Atovaquone Oral Suspension, USP 750mg/5mL to the Consumer/User level, due to the potential Bacillus cereus contamination in the product found during stability testing at a 3rd party lab. Risk Statement: In the population most at risk, immunocom

Continue ...

 PDF
Tags:   Recalls    AvKARE    LLC.    Issues    Voluntary    Nationwide    Recall    Atovaquone    Oral    Suspension    USP    750    mg/5    Due    Potential    Bacillus    Cereus    Contamination
Rating: 0.00 (0 votes) Rate this article
Bookmark and share this news item: